Literature DB >> 2659168

Non-chemotherapeutic agents that potentiate chemotherapy efficacy.

D J Stewart1, W K Evans.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2659168     DOI: 10.1016/0305-7372(89)90002-9

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  20 in total

1.  [Janus-faced character of chemotherapy: a comment on the Abel theses].

Authors:  D Schmähl
Journal:  Klin Wochenschr       Date:  1991-01-04

2.  Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. Mechanism of action.

Authors:  Y J Lidor; K C O'Briant; F J Xu; T C Hamilton; R F Ozols; R C Bast
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

3.  Current status and future directions of research on multidrug resistance. The impact of contemporary biotechnology.

Authors:  G H Mickisch
Journal:  Urol Res       Date:  1993-03

4.  Reversal of multidrug resistance by bis(phenylalkyl)amines and structurally related compounds.

Authors:  A Ramu; N Ramu
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Treatment of advanced and refractory breast cancer with doxorubicin, vincristine and continuous infusion of verapamil. A phase I-II clinical trial.

Authors:  F Ries; M Dicato
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

6.  Multiple resistance modulators combined with carboplatin for resistant malignancies: a pilot study.

Authors:  D J Stewart; R Goel; M C Cripps; S Huan; J Yau; S Verma
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

7.  Modulation of doxorubicin-toxicity by tamoxifen in multidrug-resistant tumor cells in vitro and in vivo.

Authors:  E Pommerenke; J Mattern; M Volm
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

8.  Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate.

Authors:  L Wang; C P Yang; S B Horwitz; P A Trail; A M Casazza
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Effects of verapamil on the pharmacokinetics and metabolism of epirubicin.

Authors:  K Mross; K Hamm; D K Hossfeld
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  Antitumor effects of ketoconazole and trifluoperazine in murine T-cell lymphomas.

Authors:  S Naftalovich; E Yefenof; Y Eilam
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.